Clinical Trial Update: Cangrelor to Clopidogrel or Prasugrel Transition Study [Phase 2]

View source ↗

Summary

Phase 2 trial updating on transition from cangrelor to clopidogrel or prasugrel in patients with coronary artery disease; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Cangrelor (cangrelor)
• PRASUGREL (prasugrel)

Snippet

Sponsor: The Medicines Company | Conditions: Coronary Artery Disease (CAD) | Phase 2 | Status: COMPLETED | Results posted: 2018-03-05